Molecular profiling of 6,892 colorectal cancer patients to identify potential treatment options


Wafik S. El-Deiry, Joanne Xiu, Bora Lim, Angelique Scicchitano, Eileen Feeley, Harold A. Harvey, Nelson S. Yee

Background: Colorectal cancer (CRC) especially with KRAS/BRAF mutaFon (MT) is aggressive and has limited treatment opFons when metastaFc. We used a mulFplacorm molecular profiling (MP) approach to idenFfy potenFal treatments not typically considered for CRC in order to improve the management of this disease.

Download Publication